Baricitinib in Pediatric Chronic Immune Thrombocytopenia and Associated Autoimmune Conditions: A Case Report

    December 2024 in “ Frontiers in Pediatrics
    G. López de Hontanar Torres, Josune Zubicaray, Elena Sebastián, Á. Hernández‐Martín, June Iriondo, Julián Sevilla
    Image of study
    TLDR Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.
    This case report highlights the successful use of baricitinib, a JAK 1/2 inhibitor, in a 16-year-old female with chronic immune thrombocytopenia (cITP) and alopecia areata, where conventional treatments failed. Baricitinib, used off-label, significantly improved platelet counts and alopecia, with sustained normal platelet levels post-treatment. The findings suggest baricitinib as a potential treatment for pediatric cITP with autoimmune conditions, warranting further clinical trials to validate its efficacy.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 11 results

      community What else is good. Besides the big 3.

      in Chat  34 upvotes 3 months ago
      Key treatments for hair preservation include minoxidil, finasteride/dutasteride, and microneedling, with additional options like specific shampoos, oils, biotin, zinc, tretinoin, clascoterone, and low-level laser therapy. Maintaining a healthy lifestyle, reducing stress, and addressing nutrient deficiencies can also support hair health.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

    Similar Research

    6 / 417 results